This week’s Medicare updates include manufacturer agreements for the second cycle of the Medicare Drug Price Negotiation Program, a revised memorandum on long-term care surveyor guidance, and more!
This week’s Medicare updates include the 2025 Home Health Prospective Payment System proposed rule, a list of Part B drugs with a lower coinsurance for next quarter, and more!
This week’s Medicare updates include revised guidance for the Medicare Prescription Drug Inflation Rebate Program, information on global surgery package requirements, and more!
This week’s Medicare updates include a final rule on COVID-19 vaccination requirements for healthcare staff, guidance on modifier -JZ, coverage guidelines for Alzheimer’s drugs, and more!
This week’s Medicare updates include a notice about reprocessing certain drug claims that were rejected in error, the latest version of the Medicare beneficiary COVID-19 data snapshot, a table on MAC pricing for COVID-19 testing, and more!
This week’s Medicare updates include two compliance reviews from the Office of Inspector General, an enforcement instruction on supervision requirements for outpatient therapy, clarification of instructions for medical reviews of inpatient rehabilitation facility claims, and more!
This week’s note explores the newly expanded national targeted probe and educate initiative with a focus on how processes for the program should work and what providers can do to simplify the review period.
This week’s Medicare updates include a fact sheet on the transition to new Medicare cards, a table to clarify alternative payment models’ statuses in the Quality Payment Program, a review of a health system’s compliance with inpatient rehabilitation facility service billing requirements, and more!
This week’s Medicare updates include the announcement of a new bundled payment model, clarification on CMS’ regulations regarding texting of patient information, notification of the new interest rate for overpayments and underpayments, and more!
